The FDA has announced steps to make gluten-containing ingredients more visible on food labels — and for celiac families, this could change how every shopping trip looks. An announcement from HHS.gov describes new measures aimed at closing long-standing gaps in how manufacturers must disclose gluten sources — particularly ingredients like barley and rye that can appear on labels under names most shoppers would never connect to gluten.
This matters because the current labeling system was not built with celiac disease in mind. Wheat must be declared as a major allergen under U.S. law, but barley and rye carry no such requirement. That means “malt flavoring” on a label could be from barley — a direct gluten source — with no obligation to say so. For my son and the roughly 3 million Americans living with celiac disease, that gap is not an inconvenience. It is a daily hazard.
What This Means for You
If you spend time studying food labels, you already know the problem. Ingredients like “malt,” “malt extract,” “brewer’s yeast,” and “hydrolyzed vegetable protein” can all contain gluten from barley or rye — and none of them trigger the “Contains: Wheat” declaration that federal law requires. Celiac patients are left to research every ambiguous term, call manufacturers, or skip anything uncertain.
The FDA’s announcement signals a move toward closing that gap. While specific regulatory steps are still taking shape, the direction is clear: the agency wants gluten ingredient disclosure to be more explicit, more consistent, and harder to miss. For celiac families, that could mean fewer hours spent decoding labels and more confidence that what’s in the package is actually what the label implies.
It is worth being clear about what this announcement does not yet do: it does not create new labeling rules overnight. Regulatory processes involve public comment periods, agency review, and often years between announcement and enforcement. But a formal step from the FDA means the issue has moved from the advocacy agenda to the regulatory agenda — and that shift is meaningful.
Every ingredient that currently hides gluten is a potential source of cross-contact. Every label that makes gluten visible is one fewer trap for patients and families who cannot afford to guess.
Key Takeaways
- The FDA announced steps to improve how gluten-containing ingredients, including barley and rye, are disclosed on food labels.
- Current U.S. law requires wheat to be declared as an allergen, but barley and rye have no equivalent requirement — leaving many hidden gluten sources unlabeled.
- This announcement does not create immediate new rules, but it signals that the FDA is moving toward stronger disclosure requirements.
- Celiac families, advocates, and physicians have pushed for this change for years; this is evidence that pressure is producing results.
- Full implementation will take time — the public comment period is the moment for individual patients and families to make their voices heard.
The Science
Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No regulatory background required.
Why Wheat Gets a Declaration and Barley Doesn’t
U.S. food allergen labeling is governed by two federal laws: the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA) and the FASTER Act of 2021, which added sesame as the ninth major allergen. Together, these laws require that food manufacturers declare nine specific allergens in plain language — either within the ingredient list or in a separate “Contains” statement.
Wheat is on that list. Barley and rye are not.
This distinction exists because allergen legislation was built around IgE-mediated food allergies — immune reactions driven by immunoglobulin E antibodies that produce symptoms within minutes of exposure. The nine major allergens were identified by how frequently and severely they trigger this specific immune response. Celiac disease operates through a completely different mechanism: a T-cell mediated autoimmune response to gluten — the storage proteins found in wheat, barley, rye, and for some patients, oats. Because celiac disease is not classified as an IgE-mediated allergy, barley and rye were never captured under allergen labeling law.
That regulatory mismatch created a persistent blind spot. A product containing barley malt extract — a common ingredient in cereals, flavored crackers, and condiments — is not required to declare barley as an allergen. The only obligation is to list “malt extract” in the ingredient panel, with no plain-language warning that it derives from a gluten-containing grain.
What “Gluten Ingredient Disclosure” Could Mean in Practice
The FDA’s proposed improvements could take several forms. One avenue is expanding allergen declaration requirements to include barley and rye explicitly — matching the approach already taken in the European Union, where Regulation (EU) No 1169/2011 requires labeling of all “cereals containing gluten,” including wheat, rye, barley, oats, spelt, and kamut. Under EU rules, a product containing barley malt must declare it. U.S. products currently face no equivalent obligation.
A second avenue is strengthening precautionary allergen labeling (PAL) — the voluntary “may contain” or “made in a facility that also processes wheat” statements manufacturers use to flag shared-facility or shared-equipment cross-contact risk. Currently, PAL statements for gluten are inconsistent, unverified, and carry no regulatory definition. One company’s “may contain wheat” signals a different level of risk than another’s, with no standard behind either. Clearer FDA guidance on when and how PAL statements should be used would help patients and families make better-informed choices — and give them a reason to trust the statements they see.
A third area involves ambiguous ingredient names — terms like “natural flavors,” “modified food starch,” “dextrin,” and “hydrolyzed protein” that can derive from gluten-containing grains without any indication on the label. Requiring source disclosure for these terms when they contain gluten would close a gap that trips up even experienced label readers.
International Context
This FDA action doesn’t happen in isolation. As we covered in our earlier piece on CCFL49 forwarding science-based guidance for precautionary labeling of cereals containing gluten, international food standards bodies have been advancing frameworks that go beyond what the U.S. currently requires. The Codex Alimentarius Commission — the international body that sets global food safety standards — has worked for years on consistent guidance for gluten-containing cereal labeling. FDA action that aligns U.S. policy with international standards would benefit not just celiac patients but also food manufacturers navigating different requirements across markets.
The celiac advocacy community has been central to pushing this forward. Earlier coverage here laid out the case for why clearer labeling is not a niche ask — it is a basic safety measure for millions of patients who cannot safely consume even trace amounts of gluten.
Where Things Stand
As a celiac parent, I read news like this with cautious optimism. The FDA moving in the right direction is genuinely encouraging. But regulatory announcements and regulatory enforcement are separated by a long road — and celiac families have learned to wait on that road before celebrating.
What matters now is engagement. Public comment periods are where advocacy organizations and individual patients make their voices heard on the record. The Celiac Disease Foundation, Beyond Celiac, and similar groups will almost certainly call for community participation when a proposed rule opens for comment. If you want to see this change become enforceable, that is the moment to act.
My son does not track every label he has ever read from. I do. Every vague ingredient our family has had to investigate, every manufacturer we have had to call, every product we have had to skip because the label offered no clear answer — those are the problems this regulatory change is designed to prevent. Progress is slow, but it is moving in the right direction.
Related Coverage
- FDA Moves Toward Tougher Gluten Labeling Rules
- Advocating for Clearer Labeling of Gluten in the U.S.
- CCFL49 Forwards Science-Based Guidance for Precautionary Labeling of Cereals Containing Gluten for Final Adoption
References
- U.S. Department of Health and Human Services / FDA. “FDA Takes Steps to Improve Gluten Ingredient Disclosure in Foods.” HHS.gov, January 21, 2026. Source
- Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA). Public Law 108-282.
- Food Allergy Safety, Treatment, Education, and Research (FASTER) Act of 2021. Public Law 117-11.
- European Parliament. Regulation (EU) No 1169/2011 on the provision of food information to consumers. Annex II.
- Codex Alimentarius Commission. Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten. CODEX STAN 118-1979, revised 2008.